• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺中的胆碱能和ACE-2依赖性抗炎系统:COVID-19带来的新情况

The Cholinergic and ACE-2-Dependent Anti-Inflammatory Systems in the Lung: New Scenarios Emerging From COVID-19.

作者信息

Di Maro Martina, Cataldi Mauro, Santillo Mariarosaria, Chiurazzi Martina, Damiano Simona, De Conno Barbara, Colantuoni Antonio, Guida Bruna

机构信息

Department of Clinical Medicine and Surgery, Physiology Nutrition Unit, University of Naples Federico II, Naples, Italy.

Department of Neuroscience, Reproductive Sciences and Dentistry, Division of Pharmacology, University of Naples Federico II, Naples, Italy.

出版信息

Front Physiol. 2021 May 13;12:653985. doi: 10.3389/fphys.2021.653985. eCollection 2021.

DOI:10.3389/fphys.2021.653985
PMID:34054572
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8155253/
Abstract

The renin angiotensin system and the cholinergic anti-inflammatory pathway have been recently shown to modulate lung inflammation in patients with COVID-19. We will show how studies performed on this disease are starting to provide evidence that these two anti-inflammatory systems may functionally interact with each other, a mechanism that could have a more general physiological relevance than only COVID-19 infection.

摘要

肾素血管紧张素系统和胆碱能抗炎途径最近已被证明可调节新冠肺炎患者的肺部炎症。我们将展示针对这种疾病所开展的研究如何开始提供证据,证明这两种抗炎系统可能在功能上相互作用,这种机制可能具有比仅在新冠肺炎感染中更广泛的生理相关性。

相似文献

1
The Cholinergic and ACE-2-Dependent Anti-Inflammatory Systems in the Lung: New Scenarios Emerging From COVID-19.肺中的胆碱能和ACE-2依赖性抗炎系统:COVID-19带来的新情况
Front Physiol. 2021 May 13;12:653985. doi: 10.3389/fphys.2021.653985. eCollection 2021.
2
Role of the Backbenchers of the Renin-Angiotensin System ACE2 and AT2 Receptors in COVID-19: Lessons From SARS.肾素-血管紧张素系统的ACE2和AT2受体的后座议员在COVID-19中的作用:来自SARS的教训。 (注:这里的“Backbenchers”翻译可能不太准确,原词在医学语境下可能有特定含义,需结合更专业背景理解,仅按字面翻译为“后座议员” 。整体译文仅供参考,具体需根据上下文和专业知识进一步优化。)
Cureus. 2020 Jun 2;12(6):e8411. doi: 10.7759/cureus.8411.
3
Correcting the imbalanced protective RAS in COVID-19 with angiotensin AT2-receptor agonists.用血管紧张素 AT2 受体激动剂纠正 COVID-19 中失衡的保护性 RAS。
Clin Sci (Lond). 2020 Nov 27;134(22):2987-3006. doi: 10.1042/CS20200922.
4
Angiotensin-converting enzyme as a new immunologic target for the new SARS-CoV-2.血管紧张素转化酶作为新型 SARS-CoV-2 的新免疫靶点。
Immunol Cell Biol. 2021 Feb;99(2):192-205. doi: 10.1111/imcb.12396. Epub 2020 Oct 7.
5
Effects of Angiotensin II Receptor Blockers and ACE (Angiotensin-Converting Enzyme) Inhibitors on Virus Infection, Inflammatory Status, and Clinical Outcomes in Patients With COVID-19 and Hypertension: A Single-Center Retrospective Study.血管紧张素 II 受体阻滞剂和 ACE(血管紧张素转换酶)抑制剂对 COVID-19 合并高血压患者病毒感染、炎症状态和临床结局的影响:一项单中心回顾性研究。
Hypertension. 2020 Jul;76(1):51-58. doi: 10.1161/HYPERTENSIONAHA.120.15143. Epub 2020 Apr 29.
6
Coronavirus Disease 2019 and Hypertension: The Role of Angiotensin-Converting Enzyme 2 and the Renin-Angiotensin System.2019冠状病毒病与高血压:血管紧张素转换酶2及肾素-血管紧张素系统的作用
Adv Chronic Kidney Dis. 2020 Sep;27(5):404-411. doi: 10.1053/j.ackd.2020.07.002. Epub 2020 Jul 4.
7
RAAS Blockade and COVID-19: Mechanistic Modeling of Mas and AT1 Receptor Occupancy as Indicators of Pro-Inflammatory and Anti-Inflammatory Balance.RAAS 阻断与 COVID-19:Mas 和 AT1 受体占有率的机械建模作为促炎和抗炎平衡的指标。
Clin Pharmacol Ther. 2021 Apr;109(4):1092-1103. doi: 10.1002/cpt.2177. Epub 2021 Mar 10.
8
[Renin Angiotensin Axis, Angiotensin Converting Enzyme 2 and Coronavirus].[肾素-血管紧张素轴、血管紧张素转换酶2与冠状病毒]
Rev Chil Pediatr. 2020 Jun;91(3):330-338. doi: 10.32641/rchped.vi91i3.2548.
9
The Controversy of Renin-Angiotensin-System Blocker Facilitation Versus Countering COVID-19 Infection.肾素-血管紧张素-系统阻滞剂促进与对抗 COVID-19 感染的争议。
J Cardiovasc Pharmacol. 2020 Oct;76(4):397-406. doi: 10.1097/FJC.0000000000000894.
10
Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients With Coronavirus Disease 2019: Friend or Foe?血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂在 2019 冠状病毒病患者中的应用:是敌是友?
Cardiol Rev. 2020 Jul/Aug;28(4):213-216. doi: 10.1097/CRD.0000000000000319.

引用本文的文献

1
Critically Ill COVID-19 Patients Show Reduced Point of Care-Measured Butyrylcholinesterase Activity-A Prospective, Monocentric Observational Study.重症 COVID-19 患者床旁检测的丁酰胆碱酯酶活性降低——一项前瞻性、单中心观察性研究
Diagnostics (Basel). 2022 Sep 3;12(9):2150. doi: 10.3390/diagnostics12092150.
2
Ursolic acid and SARS-CoV-2 infection: a new horizon and perspective.熊果酸与 SARS-CoV-2 感染:新的视野和展望。
Inflammopharmacology. 2022 Oct;30(5):1493-1501. doi: 10.1007/s10787-022-01038-3. Epub 2022 Aug 3.
3
Assessing Smoking Status and Risk of SARS-CoV-2 Infection: A Machine Learning Approach among Veterans.

本文引用的文献

1
Activation of the Cholinergic Anti-Inflammatory Pathway as a Novel Therapeutic Strategy for COVID-19.胆碱能抗炎途径的激活作为 COVID-19 的一种新的治疗策略。
Front Immunol. 2021 Feb 8;11:595342. doi: 10.3389/fimmu.2020.595342. eCollection 2020.
2
Nicotinic cholinergic system and COVID-19: In silico identification of interactions between α7 nicotinic acetylcholine receptor and the cryptic epitopes of SARS-Co-V and SARS-CoV-2 Spike glycoproteins.烟碱型乙酰胆碱能系统与 COVID-19:α7 型烟碱型乙酰胆碱受体与 SARS-CoV 和 SARS-CoV-2 刺突糖蛋白隐匿表位相互作用的计算鉴定。
Food Chem Toxicol. 2021 Mar;149:112009. doi: 10.1016/j.fct.2021.112009. Epub 2021 Jan 24.
3
评估吸烟状况与新型冠状病毒2感染风险:退伍军人中的一种机器学习方法
Healthcare (Basel). 2022 Jul 4;10(7):1244. doi: 10.3390/healthcare10071244.
4
COVID-19 in Joint Ageing and Osteoarthritis: Current Status and Perspectives.COVID-19 与老年共病和骨关节炎:现状与展望。
Int J Mol Sci. 2022 Jan 10;23(2):720. doi: 10.3390/ijms23020720.
5
Pathophysiology of Cardiac Injury in COVID-19 Patients with Acute Ischaemic Stroke: What Do We Know So Far?-A Review of the Current Literature.新冠病毒肺炎合并急性缺血性卒中患者心脏损伤的病理生理学:目前我们了解多少?——当前文献综述
Life (Basel). 2022 Jan 6;12(1):75. doi: 10.3390/life12010075.
Nicotinic cholinergic system and COVID-19: evaluation of nicotinic acetylcholine receptor agonists as potential therapeutic interventions.
烟碱胆碱能系统与新型冠状病毒肺炎:评估烟碱型乙酰胆碱受体激动剂作为潜在治疗干预措施的效果
Toxicol Rep. 2020 Dec 19;8:73-83. doi: 10.1016/j.toxrep.2020.12.013. eCollection 2021.
4
Human recombinant soluble ACE2 in severe COVID-19.严重新型冠状病毒肺炎中的人重组可溶性血管紧张素转换酶2
Lancet Respir Med. 2020 Nov;8(11):1154-1158. doi: 10.1016/S2213-2600(20)30418-5. Epub 2020 Sep 24.
5
A parallel-group, multicenter randomized, double-blinded, placebo-controlled, phase 2/3, clinical trial to test the efficacy of pyridostigmine bromide at low doses to reduce mortality or invasive mechanical ventilation in adults with severe SARS-CoV-2 infection: the Pyridostigmine In Severe COvid-19 (PISCO) trial protocol.一项平行组、多中心、随机、双盲、安慰剂对照、2/3 期临床试验,旨在测试低剂量溴吡斯的明在降低严重 SARS-CoV-2 感染成人死亡率或有创机械通气方面的疗效:溴吡斯的明治疗严重 COVID-19 (PISCO)试验方案。
BMC Infect Dis. 2020 Oct 16;20(1):765. doi: 10.1186/s12879-020-05485-7.
6
A Systematic Review and Meta-Analysis of Hospitalised Current Smokers and COVID-19.系统评价和荟萃分析住院吸烟者与 COVID-19 。
Int J Environ Res Public Health. 2020 Oct 11;17(20):7394. doi: 10.3390/ijerph17207394.
7
Nicotine stimulates ion transport via metabotropic β4 subunit containing nicotinic ACh receptors.尼古丁通过含有烟碱型乙酰胆碱受体的代谢型β4亚基刺激离子转运。
Br J Pharmacol. 2020 Dec;177(24):5595-5608. doi: 10.1111/bph.15270. Epub 2020 Nov 9.
8
Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option? Reply.对中国新冠肺炎住院患者当前吸烟率的系统评价:尼古丁能否成为一种治疗选择?回复。
Intern Emerg Med. 2021 Jan;16(1):235-236. doi: 10.1007/s11739-020-02457-2. Epub 2020 Sep 21.
9
Nicotine and the nicotinic cholinergic system in COVID-19.尼古丁和 COVID-19 中的烟碱型乙酰胆碱能系统。
FEBS J. 2020 Sep;287(17):3656-3663. doi: 10.1111/febs.15521. Epub 2020 Aug 25.
10
A nicotinic hypothesis for Covid-19 with preventive and therapeutic implications.一种与 COVID-19 相关的烟碱能假说及其预防和治疗意义。
C R Biol. 2020 Jun 5;343(1):33-39. doi: 10.5802/crbiol.8.